Artivion Inc AORT

NYS: AORT | ISIN: US2289031005   18/09/2026
23,35 USD (-2,22%)
(-2,22%)   18/09/2026

6 augustus 2026 · Artivion Reports Second Quarter 2026 Financial Results · Persbericht

28 juli 2026 · Artivion to Participate in Upcoming Investor Conferences · Persbericht

23 juli 2026 · Artivion Announces Release Date and Teleconference Call Details for Second Quarter 2026 Financial Results · Persbericht

29 juni 2026 · Artivion Announces U.S. FDA Approval of the AMDS Hybrid Prosthesis · Persbericht

10 juni 2026 · Artivion to Participate in the 2026 Truist Securities MedTech Conference · Persbericht

18 mei 2026 · Artivion Completes Acquisition of Endospan Ltd. · Persbericht

7 mei 2026 · Artivion Reports First Quarter 2026 Financial Results and Announces Exercise of Option to Acquire Endospan · Persbericht

23 april 2026 · Artivion Announces Release Date and Teleconference Call Details for First Quarter 2026 Financial Results · Persbericht

7 april 2026 · Artivion Announces U.S. FDA Approval of the NEXUS® Aortic Arch System · Persbericht

3 maart 2026 · Artivion to Participate in the Oppenheimer 36th Annual Healthcare MedTech & Services Conference · Persbericht

12 februari 2026 · Artivion Reports Fourth Quarter and Full Year 2025 Financial Results · Persbericht

2 februari 2026 · Artivion Announces Presentation of Positive New Clinical Data from NEXUS TRIOMPHE and AMDS PERSEVERE Trials at the 62nd Society of Thoracic Surgery Annual Meeting · Persbericht

29 januari 2026 · Artivion Announces Release Date and Teleconference Call Details for Fourth Quarter 2025 Financial Results · Persbericht

6 november 2025 · Artivion Reports Third Quarter 2025 Financial Results · Persbericht

6 november 2025 · Artivion Announces Treatment of First Patient with Arcevo LSA in ARTIZEN Pivotal Trial · Persbericht

29 oktober 2025 · Artivion to Participate in the Stifel 2025 Healthcare Conference · Persbericht

23 oktober 2025 · Artivion Announces Release Date and Teleconference Call Details for Third Quarter 2025 Financial Results · Persbericht

13 oktober 2025 · Artivion Announces Presentation of Late-Breaking Data from AMDS PERSEVERE and AMDS PROTECT Trials at the 39th European Association for Cardio-Thoracic Surgery (EACTS) Annual Meeting · Persbericht

5 september 2025 · Artivion to Participate in Morgan Stanley 23rd Annual Global Healthcare Conference · Persbericht

7 augustus 2025 · Artivion Reports Second Quarter 2025 Financial Results · Persbericht

Mijn selecties